Theranostics: Paintball targeting of cancer cells combined with precision therapySeptember 13, 2017
RESTON, Va. - The Journal of Nuclear Medicine's September 2017 supplement shines a spotlight on theranostics and its increasingly important role in the delivery of precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed -- minimizing side effects and improving quality of life for patients.
"Theranostics is the future of precision medicine," explains Wolfgang A. Weber, MD, chief of the Molecular Imaging and Therapy Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. "Therapies are not selected based on genetic mutations that may or may not be present in all cancer cells, but on imaging the whole patient and determining if a specific treatment can be effective. Because of the specific targeting of the cancer cells, theranostic agents are extremely well tolerated."
This JNM Supplement on Clinical and Translational Theranostics is edited by Ken Herrmann, MD, MBA, chair of nuclear medicine at the University of Duisburg-Essen, Essen, Germany, and Steven M. Larson, MD, and Weber, both at MSKCC. Their introductory article points out that theranostics is "more than just a fashion trend." It notes that "the idea of using a radioactive compound for diagnostic imaging, target-expression confirmation, and radionuclide therapy dates back to 1946, when Seidlin et al. published the first study on radioiodine therapy for metastatic thyroid cancer. More recently, sodium-iodine-124 and sodium-iodine-131 (Na124I/Na131I) have become important for thyroid cancer monitoring.
Today, Herrmann says, "The theranostic concept has gained new momentum with the recent success of peptide receptor radioligand therapy (PRRT) in neuroendocrine tumors (NETs)." He adds, "The current expansion of this concept to prostate cancer targeting the prostate specific membrane antigen (PSMA) is bringing theranostics to another level. Both are already in clinical use, with PRRT for NETs awaiting FDA approval at any moment."
Articles in the JNM supplement cover research on multireceptor targeting and new strategies for both PSMA imaging/therapy and targeting the somatostatin receptor (so effectively used in PRRT for NETs), as well as exciting research on theranostics for other cancers, including intraarterial yttrium-90 (90Y) therapy for liver metastases. Herrmann points out, "Additional promising theranostic research includes targeting the CXCR4-receptor in hematooncological tumors, the neurotensin 1 receptor in pancreatic cancer, Ewing sarcoma and gastrointestinal tumors, as well as alpha-MSH1 [alpha-melanocyte-stimulating hormone 1] in melanoma."
For nuclear medicine, Weber says, "Theranostics will be practice-changing. Right now, nuclear medicine is dominated by hybrid imaging (PET/CT, SPECT/CT). Theranostics will bring therapy and patient care to the center of nuclear medicine. In other words, the field will change from 'nuclear radiology' to true 'nuclear medicine.'"
Weber emphasizes, "The most important future development is to combine theranostics with other cancer therapies and use theranostics earlier in the course of disease in order to achieve not only prolongation of survival, but cures."
As Herrmann notes, "This is just the beginning of the era of theranostics!"
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI's more than 15,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.
Society of Nuclear Medicine
Related Cancer Cells Articles:
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Related Cancer Cells Reading:
Your Fourth Choice: Killing Cancer Cells with Paw Paw - that Little-Known Treatment that Grows on Trees
by John Clifton (Author)
Author John Clifton begins with the story of his wife, who was diagnosed with Stage Four lung cancer. The bad news came on Christmas Eve, 2012. The prognosis from the oncologists was bleak. But Clifton decided to explore natural treatments. After all, there was nothing to lose. After sifting through tons of purported "remedies" and "cures," he came upon information about something called "paw paw." It was an extract from an American tree. To his surprise, this little-known treatment had been thoroughly studied and tested- for THIRTY YEARS! The success rate was amazing, and even more startling... View Details
One Renegade Cell: How Cancer Begins (Science Masters Series)
by Robert A. Weinberg (Author)
Cancer research has reached a major turning point, and no one is better qualified to explain the past two deacades' dramatic leaps forward in understanding this disease than world-renowned molecular biologist Robert Weinberg, director of the Oncology Research Laboratory at the Whitehead Institute in Cambridge, Massachusetts. In One Renegade Cell, Weinberg presents a state-of-the-art account of how cancer begins and how, one day, it will be cured. View Details
Essential Oils And Cancer: How To Effectively Use The Right Essential Oils To Confuse And Kill Cancer Cells
by Nancy Dennett Ducharme (Author)
Essential oils have been used for centuries to help support the immune system and bring the body back to health. This first book in the Essential Oils And Cancer series shows step by step exactly how to use essential oils to fight cancer. Learn how to prepare and use the compounds in two specific plant species to attack and destroy abnormal cells and cell mutations that have grown out of control. Learn which combinations of essential oils to use with breast cancer, bone cancer, lung cancer, skin cancer, prostate cancer, and other cancers according to latest scientific research. View Details
Killing Cancer With Spices: Cancer Stem Cells - Inflammation
by James A McCraw Jr (Author)
Killing Cancer With Spices-4 spices that will kill cancer stem cells-2 Supplements that will kill cancer stem cells- View Details
The Biology of Cancer, 2nd Edition
by Robert A. Weinberg (Author), Robert A Weinberg (Author)
Thoroughly updated and incorporating the most important advances in the fast-growing field of cancer biology, The Biology of Cancer, Second Edition, maintains all of its hallmark features admired by students, instructors, researchers, and clinicians around the world.
The Biology of Cancer is a textbook for students studying the molecular and cellular bases of cancer at the undergraduate, graduate, and medical school levels. The principles of cancer biology are presented in an organized, cogent, and in-depth manner. The clarity of writing, supported by an extensive... View Details
Cancer: The Outlaw Cell
by Richard LaFond (Editor)
We live in an era in which scientific information grows by the day and is so specialized that no one person can possibly absorb and kept abreast of the literature. Substantial developments in science and medicine, powered by developing technologies such as genetic sequencing, proteomics, and nanobiology, have driven cancer research forward, and a review of where we are now is desperately needed.
Cancer: The Outlaw Cell is a collection of twenty-five focused chapters written by leading researchers at the forefront of cancer research. Authors present the current state of... View Details
Disconnect: The Truth About Cell Phone Radiation
by Devra Davis (Author)
"As [Disconnect] shows, cell phones may actually be doing damage to far more than our attention spans-and could, in fact, be killing us." -Salon.com. Since the invention of radar, cell phone radiation was assumed to be harmless because it wasn't like X-rays. But a sea change is now occurring in the way scientists think about it. The latest research ties this kind of radiation to lowered sperm counts, an increased risk of Alzheimer's, and even cancer. In Disconnect, National Book Award finalist Devra Davis tells the story of the dangers that the cell phone industry is knowingly exposing us-and... View Details
Cancer and Sickle Cell Disease (Living With Diseases and Disorders)
by Hilary W Poole (Author)
Explains how cancer and sickle cell anemia occur and how they can be treated, and it also provides supportive advice for kids who have to deal with these conditions. View Details
The Cancer Fighting Diet: Diet and Nutrition Strategies to Help Weaken Cancer Cells and Improve Treatment Results
by Dr. Johannes Coy Sc.D. (Author), Maren Franz (Author)
This book provides basic information about cancer, as well as detailed advice and a comprehensive diet plan to help fight a personal battle with cancer and significantly improve chances of a cure.
There are complex processes inside the human body and specific mechanisms that can lead to the development and spread of cancer cells. Understanding the causes for what is happening inside the body is the key to implementing the recommendations in this guide.
Using these recipes and nutritional strategies will cut dramatically down on sugar in order to deplete the strength and... View Details
Cancer Stem Cells
by William L. Farrar PhD (Editor)
A remarkable paradigm shift has occurred in recent years regarding the biological origins of cancer. The cancer stem cell hypothesis has challenged the foundational notions of cancer, and the therapeutic implications have been profound. Compelling evidence indicates that errors in the development of a small subset of adult stem cells can lead to cancer. Only this small sub-population of cells has the inherent ability to form tumors and metastasize. This book discusses the emerging field of cancer stem cell research, with contributions from leading experts on the basic biology, genetic... View Details